Location History:
- Reykjavik, IS (2008)
- Freiburg, DE (2013)
Company Filing History:
Years Active: 2008-2013
Title: Bjorn Mamat: Innovator in Inflammatory Disease Treatment
Introduction
Bjorn Mamat is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating inflammatory diseases. With a total of two patents to his name, Mamat's work is recognized for its potential impact on healthcare.
Latest Patents
Mamat's latest patents include innovative biaryl substituted heterocycle inhibitors of LTA4H (leukotriene A4 hydrolase). These compounds are designed for the treatment, prevention, and prophylaxis of inflammatory diseases and disorders. The general formula of these compounds showcases their unique chemical structure, which is pivotal in their function as inhibitors.
Career Highlights
Throughout his career, Bjorn Mamat has worked with prominent companies, including Decode Genetics Ehf. His experience in the biotechnology sector has equipped him with the knowledge and skills necessary to advance his research and inventions.
Collaborations
Mamat has collaborated with notable professionals in his field, including Vincent Premaratna Sandanayaka and Jasbir Singh. These collaborations have likely contributed to the depth and breadth of his research endeavors.
Conclusion
Bjorn Mamat's innovative work in developing treatments for inflammatory diseases highlights his role as a significant contributor to medicinal chemistry. His patents reflect a commitment to improving healthcare outcomes through scientific advancement.